Page last updated: 2024-09-03

ym 529 and Prostatic Neoplasms

ym 529 has been researched along with Prostatic Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Kinoshita, H; Matsuda, T; Sugi, M; Taniguchi, H; Yanishi, M; Yoshida, T1
Keller, ET; Miwa, S; Mizokami, A; Namiki, M; Taichman, R; Zhang, J1
Ashimine, S; Hatano, T; Horiguchi, Y; Maeda, H; Ochiai, A; Ogawa, Y; Tachibana, M; Yonou, H; Yoshioka, K1

Trials

1 trial(s) available for ym 529 and Prostatic Neoplasms

ArticleYear
A randomized, open-label, controlled trial of monthly oral minodronate or semiannual subcutaneous injection of denosumab for bone loss by androgen deprivation in Asian men with prostate cancer: the PRevention of Osteopenia with Minodronate And DEnosumab (
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2020, Volume: 31, Issue:7

    Topics: Androgen Antagonists; Androgens; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Denosumab; Diphosphonates; Humans; Imidazoles; Injections, Subcutaneous; Male; Prostatic Neoplasms

2020

Other Studies

2 other study(ies) available for ym 529 and Prostatic Neoplasms

ArticleYear
The bisphosphonate YM529 inhibits osteolytic and osteoblastic changes and CXCR-4-induced invasion in prostate cancer.
    Cancer research, 2005, Oct-01, Volume: 65, Issue:19

    Topics: Animals; Bone Marrow; Bone Neoplasms; Cell Growth Processes; Cell Line, Tumor; Chemokine CXCL12; Chemokines, CXC; Diphosphonates; Humans; Imidazoles; Male; Mice; Mice, SCID; Neoplasm Invasiveness; Osteoblasts; Prostatic Neoplasms; Receptors, CXCR4; Xenograft Model Antitumor Assays

2005
The bisphosphonate YM529 inhibits osteoblastic bone tumor proliferation of prostate cancer.
    The Prostate, 2007, Jun-15, Volume: 67, Issue:9

    Topics: Animals; Bone Neoplasms; Diphosphonates; Humans; Imidazoles; Male; Mice; Mice, Nude; Neoplasm Transplantation; Osteoblasts; Prostatic Neoplasms; Transplantation, Heterologous

2007